ArticleViruses2021
Evaluation of
Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Vector competence for Oropouche virus: A systematic review of pre-2024 experiments.PLoS neglected tropical diseases · 2025Pooled it
- (Re-)Emergence of Oropouche Virus (OROV) Infections: Systematic Review and Meta-Analysis of Observational Studies.Viruses · 2024Pooled it
- Low Generation Culex quinquefasciatus from Texas and Culex pipiens from New Jersey Are Incompetent Vectors for Oropouche Virus.The American journal of tropical medicine and hygiene · 2026Article
- Protocol for arbovirus infection of Aedes aegypti by intrathoracic microinjection or artificial blood feeding.STAR protocols · 2026Article
- Are mosquito species present in Spain competent for Oropouche virus?Parasites & vectors · 2026Article
- Dynamics and ecology of a multistage expansion of Oropouche virus in Brazil.Nature ecology & evolution · 2026Article
- What are the vector species of the Oropouche virus?Pest management science · 2026Review
- The global outbreak of Oropouche virus: surveillance of global trends.Tropical diseases, travel medicine and vaccines · 2026Review
- Article
- Low risk of transmission of prototype and newly emerged Oropouche virus strains by European Culex pipiens, Aedes albopictus, and Anopheles atroparvus mosquitoes.PLoS neglected tropical diseases · 2026Article
- Enhanced virulence and neuroinvasion of contemporaryFrontiers in microbiology · 2026Article
- Review
- From models to medicine: systematic development and evaluation of animal models forFrontiers in immunology · 2026Review
- [Between the unknown and the emerging: mapping the Oropouche and Mayaro viruses in Brazil].Cadernos de saude publica · 2026Article
- Preclinical Models of Oropouche Virus Infection and Disease.Pathogens (Basel, Switzerland) · 2025Review
- Anthropophagic Florida mosquito species are poor vectors of prototype and emerging strains of oropouche virus.PLoS neglected tropical diseases · 2025Article
- Assessment of the monthly risk of dirofilariosis infection in Europe and its projection to 2100 under climate change from a One Health perspective.Parasites & vectors · 2025Article
- Charting the Proteins of Oropouche Virus.Viruses · 2025Review
- Oropouche Virus: An Emerging Arboviral Threat and Its Implications for Europe.Life (Basel, Switzerland) · 2025Review
- Case series of Oropouche fever among travellers returning from Cuba to Spain, 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence of new human viral pathogens and re-emergence of several diseases are of particular concern in the last decades.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.